|
Paietta, E; Nelson, D L; Andersen, J et al. (1995) Levels of soluble interleukin-2 receptors are predictive of response in patients treated with interleukin-2 and lymphokine-activated killer cells. Med Oncol 12:121-4
|
|
Oleksowicz, L; Strack, M; Dutcher, J P et al. (1994) A distinct coagulopathy associated with interleukin-2 therapy. Br J Haematol 88:892-4
|
|
Baker, H; Marcus, S L; Petrylak, D P et al. (1992) Effect of interleukin-2 on some micronutrients during adoptive immunotherapy for various cancers. J Am Coll Nutr 11:482-6
|
|
Jackson, B S; Strauman, J; Frederickson, K et al. (1991) Long-term biopsychosocial effects of interleukin-2 therapy. Oncol Nurs Forum 18:683-90
|
|
Walewski, J; Paietta, E; Dutcher, J et al. (1989) Evaluation of natural killer and lymphokine-activated killer (LAK) cell activity in vivo in patients treated with high-dose interleukin-2 and adoptive transfer of autologous LAK cells. J Cancer Res Clin Oncol 115:170-4
|
|
Baker, H; Marcus, S L; Frank, O et al. (1989) Interleukin-2 enhances biopterins and catecholamines production during adoptive immunotherapy for various cancers. Cancer 64:1226-31
|
